{
  "slug": "cjc-1295-dac",
  "name": "CJC-1295-DAC",
  "aliases": ["CJC-1295 with DAC", "Drug Affinity Complex"],
  "category_tags": ["growth", "recovery", "metabolic"],
  "typical_route": ["subQ"],
  "overview": "A modified growth hormone-releasing hormone (GHRH) analog with an added Drug Affinity Complex (DAC) that extends its half-life. This allows for less frequent dosing compared to standard CJC-1295.",
  "what_people_seek": ["growth hormone optimization", "body composition", "recovery enhancement", "anti-aging effects"],
  "evidence_level": "Moderate",
  "risk_level": "Moderate",
  "side_effects_common": ["injection site reactions", "headache", "flushing", "dizziness", "fatigue", "water retention"],
  "who_should_avoid": ["pregnancy or breastfeeding", "active malignancy or cancer history", "diabetic retinopathy", "severe illness or post-surgical recovery", "hypersensitivity to components"],
  "interactions_notes": "May affect glucose metabolism and insulin sensitivity. Can interact with diabetes medications, thyroid medications, and corticosteroids. Comprehensive medication review with clinician required.",
  "dosing_ranges_literature": "Research protocols have used doses ranging from 0.5-2 mg administered once or twice weekly due to extended half-life from DAC modification.",
  "reconstitution": {
    "vial_total_mg": 2,
    "common_diluents_ml": [2, 3],
    "example_doses_mg": [0.5, 1, 2]
  },
  "storage_notes": "Store unreconstituted peptide in freezer (-20Â°C or colder). After reconstitution with bacteriostatic water, store refrigerated and use within 2-3 weeks.",
  "references": [
    {
      "id": "ref1",
      "title": "Modified GRF(1-29) with extended half-life",
      "source": "PubMed",
      "year": 2009,
      "url": "https://pubmed.ncbi.nlm.nih.gov/",
      "note": "Study on DAC technology and extended peptide half-life."
    },
    {
      "id": "ref2",
      "title": "Growth hormone releasing peptides in aging",
      "source": "Review",
      "year": 2014,
      "url": "https://pubmed.ncbi.nlm.nih.gov/",
      "note": "Overview of GHRH analogs and their clinical applications."
    }
  ],
  "last_reviewed": "2025-11-03"
}
